(Q37642755)

21 August 2017

1 reference

title

Non-adherence to statin therapy: a major challenge for preventive cardiology (English)

1 reference

21 August 2017

1 reference

T R Bates

1

1 reference

21 August 2017

V M Connaughton

series ordinal

2

1 reference

21 August 2017

G F Watts

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Expert Opinion on Pharmacotherapy

21 August 2017

published in

1 reference

21 August 2017

volume

10

1 reference

21 August 2017

issue

18

1 reference

21 August 2017

page(s)

2973-2985

1 reference

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effects of statins on bone mineral density: a meta-analysis of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Impact of medication therapy discontinuation on mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Impact of adherence to statins on coronary artery disease in primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effect of statin adherence on cerebrovascular disease in primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Pharmacoeconomic impact of non-compliance with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Centralized Pan-European survey on the undertreatment of hypercholesterolaemia (CEPHEUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Statin adherence and risk of accidents: a cautionary tale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Health psychology: mapping biobehavioral contributions to health and illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Health promotion by social cognitive means

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Patient-doctor communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Does the physician's emotional intelligence matter? Impacts of the physician's emotional intelligence on the trust, patient-physician relationship, and satisfaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

SLCO1B1 variants and statin-induced myopathy--a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Strategies for enhancing patient compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effects of a videotape information intervention at discharge on diet and exercise compliance after coronary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised con

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

An intervention study to enhance medication compliance in community-dwelling elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

A Telecommunications System for Monitoring and Counseling Patients With Hypertension Impact on Medication Adherence and Blood Pressure Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Automated telephone conversations to assess health behavior and deliver behavioral interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Visualizing coronary calcium is associated with improvements in adherence to statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

How do providers assess antihypertensive medication adherence in medical encounters?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Transition toward a nurse practitioner-managed clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Safety and efficacy of statins in Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effect of coenzyme q10 on myopathic symptoms in patients treated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effectiveness of thrice weekly ezetimibe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Narrative review: statin-related myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

Long-term adherence to statin treatment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903376186

10.1517/14656560903376186

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference